DK2490A - Rekombinante fibroblastvaekstfaktorer - Google Patents

Rekombinante fibroblastvaekstfaktorer

Info

Publication number
DK2490A
DK2490A DK002490A DK2490A DK2490A DK 2490 A DK2490 A DK 2490A DK 002490 A DK002490 A DK 002490A DK 2490 A DK2490 A DK 2490A DK 2490 A DK2490 A DK 2490A
Authority
DK
Denmark
Prior art keywords
growth factors
fibroblast growth
recombinant fibroblast
recombinant
factors
Prior art date
Application number
DK002490A
Other languages
Danish (da)
English (en)
Other versions
DK2490D0 (da
Inventor
John C Fiddes
Judith A Abraham
Andrew Protter
Original Assignee
Biotechnology Res Ass
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnology Res Ass filed Critical Biotechnology Res Ass
Publication of DK2490D0 publication Critical patent/DK2490D0/da
Publication of DK2490A publication Critical patent/DK2490A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/501—Fibroblast growth factor [FGF] acidic FGF [aFGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK002490A 1987-07-07 1990-01-05 Rekombinante fibroblastvaekstfaktorer DK2490A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7079787A 1987-07-07 1987-07-07
PCT/US1988/002264 WO1989000198A1 (en) 1987-07-07 1988-07-06 Recombinant fibroblast growth factors

Publications (2)

Publication Number Publication Date
DK2490D0 DK2490D0 (da) 1990-01-05
DK2490A true DK2490A (da) 1990-03-06

Family

ID=22097443

Family Applications (1)

Application Number Title Priority Date Filing Date
DK002490A DK2490A (da) 1987-07-07 1990-01-05 Rekombinante fibroblastvaekstfaktorer

Country Status (7)

Country Link
EP (2) EP0298723A1 (ja)
JP (4) JP2879148B2 (ja)
AU (1) AU629176B2 (ja)
CA (1) CA1341639C (ja)
DK (1) DK2490A (ja)
IL (1) IL87025A (ja)
WO (1) WO1989000198A1 (ja)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2526965B2 (ja) * 1987-02-24 1996-08-21 武田薬品工業株式会社 ムテイン，ｄｎａおよびその用途
US5852177A (en) * 1987-02-24 1998-12-22 Takeda Chemical Industries, Ltd. Basic fibroblast growth factor (bFGF) muteins
US5223483A (en) * 1987-10-22 1993-06-29 Merck & Co., Inc. Cysteine-modified acidic fibroblast growth factor
US5312911A (en) * 1987-10-22 1994-05-17 Merck & Co., Inc. Cysteine-modified acidic fibroblast growth factor
AU617795B2 (en) * 1988-03-17 1991-12-05 Leukotech A/S Heparin-binding proteins, dna coding for them, processes for producing them as well as therapeutic preparations containing them
US5814602A (en) * 1988-03-17 1998-09-29 Novo Nordisk A/S Heparin-binding proteins
GB2223497B (en) * 1988-08-08 1992-04-01 British Bio Technology Synthetic gene encoding human beta endothelial cell growth factor
GB2223495B (en) * 1988-08-08 1992-05-20 British Bio Technology Synthetic gene encoding basic fibroblast growth factor
GB2223496B (en) * 1988-08-08 1992-05-27 British Bio Technology Synthetic gene encoding mature human acid fibroblast growth factor
US5175147A (en) * 1988-08-19 1992-12-29 Takeda Chemical Industries, Ltd Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract
GB8821795D0 (en) * 1988-09-16 1988-10-19 Erba Carlo Spa New derivatives of human/bovine basic fibroplast growth factor
FR2642086B1 (fr) * 1989-01-26 1992-09-04 Sanofi Sa Gene recombinant codant pour un facteur basique de croissance des fibroblastes et ledit facteur
US7238673B2 (en) 1989-03-31 2007-07-03 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
CA2015313A1 (en) * 1989-04-26 1990-10-26 Masaharu Senoo Glycosylated fgf and production thereof
US5464943A (en) * 1989-04-26 1995-11-07 Takeda Chemical Industries, Ltd. DNA encoding glycosylated FGF and production thereof
EP0406738A3 (en) * 1989-07-03 1991-08-14 Takeda Chemical Industries, Ltd. Production of acidic fgf protein
JPH0343088A (ja) * 1989-09-29 1991-02-25 Takeda Chem Ind Ltd ａＦＧＦ蛋白質の製造法
EP0420222A1 (en) * 1989-09-29 1991-04-03 Takeda Chemical Industries, Ltd. Mutein of acidic FGF, and its production
JPH047617A (ja) * 1990-04-26 1992-01-13 Canon Inc 電子機器
DE69129113T2 (de) * 1990-06-08 1998-10-15 Sloan Kettering Inst Cancer Stimulierung der stroma- und vorläuferzellen im knochenmark
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
ES2087207T3 (es) * 1990-11-23 1996-07-16 American Cyanamid Co Factor del crecimiento de fibroblasto quimerico.
US5206354A (en) * 1990-11-23 1993-04-27 American Cyanamid Company Dna sequence encoding active fragment of fibroblast growth factor, hbf-2
IE914393A1 (en) * 1990-12-18 1992-07-01 Amgen Inc Analogs of acidic fibroblast growth factor having enhanced¹stability and biological activity
GR1002610B (el) * 1991-01-02 1997-02-20 Johnson & Johnson Consumer Products Inc. Θεραπευτικες συνθεσεις πληγων που περιεχουν παραγοντα αναπτυξης ινοβλαστων και ασκορβικον οξυ.
EP0499242B1 (en) * 1991-02-15 1996-06-26 Takeda Chemical Industries, Ltd. Stimulation of endosteal bone formation with a cell growth factor
US5192312A (en) * 1991-03-05 1993-03-09 Colorado State University Research Foundation Treated tissue for implantation and methods of treatment and use
US5492894A (en) * 1991-03-21 1996-02-20 The Procter & Gamble Company Compositions for treating wrinkles comprising a peptide
JP3303211B2 (ja) * 1991-04-26 2002-07-15 武田薬品工業株式会社 ｂＦＧＦムテインおよびその製造法
JPH07504160A (ja) * 1991-11-27 1995-05-11 インスティチュート　オブ　モレキュラー　バイオロジー　インク 骨の再生
US5461029A (en) * 1992-04-24 1995-10-24 American Cyanamid Company Method of treating herpes viral infections using HBNF and MK proteins
US5814605A (en) * 1993-03-26 1998-09-29 Amgen Inc. Therapeutic uses of keratinocyte growth factor
TW275068B (ja) * 1993-09-24 1996-05-01 American Cyanamid Co
AU1931495A (en) * 1994-03-14 1995-10-03 Cryolife, Inc. Treated tissue for implantation and preparation methods
AU714165B2 (en) * 1995-06-05 1999-12-23 Human Genome Sciences, Inc. Human criptin growth factor
US6743422B1 (en) 1996-10-15 2004-06-01 Amgen, Inc. Keratinocyte growth factor-2 products
US6214795B1 (en) * 1996-11-12 2001-04-10 Praecis Pharmaceuticals, Inc. Peptide compounds useful for modulating FGF receptor activity
AU3170499A (en) * 1998-04-28 1999-11-16 Eisai Co. Ltd. Fibroblast growth factor mutein compositions and methods of use therefor
US7252818B2 (en) 1998-07-24 2007-08-07 Cardiovascular Biotherapeutics, Inc. Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
EP1246843A1 (en) * 2000-01-05 2002-10-09 ZymoGenetics, Inc. Novel fgf homolog zfgf12
WO2001049849A1 (en) * 2000-01-05 2001-07-12 Zymogenetics, Inc. Novel fgf homolog zfgf11
AU2001288256B2 (en) * 2000-08-15 2006-03-30 New Technologies Holdings Pte Ltd A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
WO2006115118A1 (ja) 2005-04-22 2006-11-02 Eagle Industry Co., Ltd. メカニカルシール装置、摺動部品およびその製造方法
US7816140B2 (en) 2005-06-14 2010-10-19 The United States Of America As Represented By The Department Of Veterans Affairs Composition and methods for osteogenic gene therapy
WO2013090919A1 (en) * 2011-12-16 2013-06-20 Wisconsin Alumni Research Foundation Fgf-2 having enhanced stability
CN103882028B (zh) * 2014-03-18 2016-08-31 杨霞 重组人碱性成纤维细胞生长因子蛋白的制备方法
US12103953B2 (en) 2019-11-25 2024-10-01 Korea Institute Of Ocean Science Technology FGF2 polypeptide with improved temperature stability and protease resistance and use thereof
CN117486996B (zh) * 2023-12-21 2024-03-19 朗肽生物制药股份有限公司 一种改构的重组人酸性成纤维细胞生长因子的制备及其在皮肤修复中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI82266C (fi) * 1982-10-19 1991-02-11 Cetus Corp Foerfarande foer framstaellning av il-2 -mutein.
US4956455A (en) * 1984-03-05 1990-09-11 The Salk Institute For Biological Studies Bovine fibroblast growth factor
US4868113A (en) * 1986-03-03 1989-09-19 Rorer Biotechnology, Inc. Recombinant DNA vector encoding human endothelial cell growth factor

Also Published As

Publication number Publication date
DK2490D0 (da) 1990-01-05
IL87025A0 (en) 1988-12-30
JPH11103875A (ja) 1999-04-20
WO1989000198A1 (en) 1989-01-12
JPH11103874A (ja) 1999-04-20
AU2084688A (en) 1989-01-30
JPH11103876A (ja) 1999-04-20
IL87025A (en) 1993-05-13
JP2879148B2 (ja) 1999-04-05
EP0377579A1 (en) 1990-07-18
EP0298723A1 (en) 1989-01-11
AU629176B2 (en) 1992-10-01
JPH03504916A (ja) 1991-10-31
CA1341639C (en) 2014-07-08
JP2953574B2 (ja) 1999-09-27
JP2953573B2 (ja) 1999-09-27

Similar Documents

Publication Publication Date Title
DK2490D0 (da) Rekombinante fibroblastvaekstfaktorer
DE3890874C5 (de) Rekombinante Viren
DK603888A (da) Rekombinant virus
DK97790D0 (da) Renin-inhiberende peptider
YU163289A (en) Recombinant animal somatotropine
FI892714A0 (fi) Rekombinant-coccidiosisvaccin.
DK580888A (da) Mejetaersker
DK353788D0 (da) Polypeptidderivater
DK354389D0 (da) Polypeptid
NO169173C (no) Veksthormon-frigjoerende peptider
KR960016703B1 (en) Recombinant avipoxvirus
FI895456A0 (fi) Rekombinant interleukin 2-hybridproteiner.
DK492588A (da) Merozoit-antigen polypeptider
DK555488D0 (da) Sekretionssignal
DK472189A (da) Vaeksthormon
DK652788A (da) Glycoprotein
PT86162A (en) Recombinant protein expression
DK596888A (da) Rekombinant lymfotoksin
IE882056L (en) Recombinant fibroblast growth factors
ZA908042B (en) Recombinant growth factors
DK624089A (da) Polypeptidforbindelser
KR890006141U (ko) 신변장신구
BR6701997U (pt) Toalha de mesa
DE3687042D1 (de) Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.
AU622708C (en) Fibroblast growth factor antagonists

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment